“There is growing demand for what this conference provides, and no other conference offering this level of accredited education and expertise.”

ST. LOUIS, Mo. (PRWEB)
May 25, 2023

The American College of Lifestyle Medicine (ACLM) today announced the keynote speaker lineup for its 2023 Lifestyle Medicine Annual Conference, to be held October 29 to November 1, 2023, in person at the Gaylord Rockies Resort in Denver, CO, as well as virtually. The hybrid event will showcase practical ways lifestyle medicine is changing the face of medical education and clinical practice to restore health to those living with chronic diseases. Presenting sponsor for the event is Lore Health, an ACO that uses an online community to help patients discover, create and share ideas to change their lifestyles in ways right for them.

Serving as the annual conference of the nation’s fastest growing medical professional association, LM2023 is for primary care and specialist MDs and DOs, physician associates, nurses, nurse practitioners, pharmacists, registered dietitians, exercise physiologists, physical therapists, occupational therapists, respiratory therapists, social workers, speech audiologists, psychologists, health coaches, healthcare executives, students, medical residents and others seeking to learn more about lifestyle medicine and/or establish or grow lifestyle medicine practices.

Some of the featured keynote speakers and topics include:

•     Dean Ornish, MD, FACLM–Alzheimer’s research and the unifying theory of lifestyle medicine
•     James Gordon, MD–mental health, trauma, and resilience
•     Christina Economos, PhD–pediatric health and behavior change
•     Anna Lembke, MD–addiction medicine
•     Walter Willett, MD, DrPH; Frank Hu, MD, PhD; and Neha Pathak, MD, DipABLM–nutrition for optimal human and planetary health
•     Beth Frates, MD, FACLM, DipALM; Jessica Matthews, DBH, MS, NBC-HWC, DipACLM, FACLM; Ruth Wolever, PhD; Mark Faries, PhD; and Joe Kvedar, MD–behavior change
•     Michael Greger, MD, FACLM, DipABLM—nutrition and longevity
•     Cedric Bryant, PhD, FACSM; Dan Bornstein, PhD; Col. Mary Anne Kiel, MD, FAAP, DipABLM; Bryant Webber, MD, MPH; and Rob Wilkins—physical activity and military health
•     Padmaja Patel, MD, DipABLM, FACLM; Kameron Matthews, MD, JD, FAAFP; Wayne Dysinger, MD, MPH, DipABLM, FACLM; and Bharati Kolte, MD, DipABLM—transforming primary care

In addition to its line-up of keynote speakers, the conference will include concurrent sessions, pre- and post-conference workshops, an exhibitor pavilion, the annual Lifestyle Medicine Awards Celebration, and networking opportunities with medical professionals and industry leaders.

Concurrent sessions for the in-person event will be offered in four tracks: Allied Health Professionals; the Business of Lifestyle Medicine; the Science of Lifestyle Medicine; and the “How” of Lifestyle Medicine.

The Allied Health Professionals track will have topics of relevance to the clinical practice of registered dietitians, nurses, physical therapists, occupational therapists, pharmacists, behavioral health providers, and health and wellness coaches. The Business of Lifestyle Medicine track will have presentations designed to demonstrate the value of LM approaches to health systems executives, employers, insurance companies, and entrepreneurial start-ups as well as presentations on clinical models that are successfully creating improved health outcomes while being financially sustainable. The Science of Lifestyle Medicine track will provide attendees with innovative, evidence-based scientific updates to incorporate into practice, to educate patients and colleagues, and to advance their own research projects. The “How” of Lifestyle Medicine track will have presentations related to implementation of lifestyle medicine services in practice, including shared medical appointments, team-based care and health equity programs that reach vulnerable populations.

Topics of concurrent sessions will include: mindfulness for stress management; impact of nutrition in type 2 diabetes; lifestyle medicine in hormonal disorders; thriving through menopause; strengthening neuroplasticity in substance use recovery; tailoring lifestyle medicine to underserved communities; lifestyle medicine in treatment of pediatric and adult obesity; behavior change and patient engagement; the business case for lifestyle medicine; and much more.

A wide array of both pre- and post-conference in-depth workshops will be offered in-person and virtually as part of the registration process at an additional registration fee. These will cover implementing lifestyle medicine in: the evaluation and management of sleep disturbances; interventions for sarcopenia and osteoporosis; trauma-informed care; shared medical appointments; women’s mental health across the lifespan; cognition; resistance training; the workplace; personal and planetary health; stress and anxiety in primary care; endocrinology; building a successful outpatient practice; reimbursement for lifestyle medicine services and evaluating and managing psychiatric and constitutional symptoms. In-person workshops are only available for in-person attendees.

Attendees may receive credit for the lifestyle medicine-related content/sessions. The conference has been approved for AMA PRA Category 1 Credit™️. Attendees will have 60 days post conference to claim CME. Recordings will be available for one year. Workshops will not be recorded.

“More than ever, the time for lifestyle medicine is now. Physicians and other clinicians desiring health restoration as their clinical outcome goal and therefore a return to true healing would benefit greatly from this conference,” said ACLM President Beth Frates, MD, FACLM, DipABLM. “This is the place to learn more about treating the root cause of disease using all six pillars of lifestyle medicine with the latest evidence-based science, plus thought leadership and inspiring networking with colleagues from across the country and all over the world.”

“There is growing demand for what this conference provides, and no other conference offers this level of accredited education and expertise,” said 2023 Conference Chair Meagan L. Grega, MD, FACLM, DipABLM. “As the nation’s only medical professional society dedicated to lifestyle medicine, ACLM continues to fill the industry’s knowledge gap and provide the networking necessary to catalyze a paradigm shift in the delivery of healthcare. Join us to learn how you can be part of lifestyle medicine becoming the foundation of health and all healthcare.”

In-person and virtual general registration pricing is dependent on timing of registration. For more information about the conference, pricing, or to register, see CME/CE Conference – American College of Lifestyle Medicine.

General in-person registration will close on October 2, 2023, or when the 1,900-person maximum in-person capacity for the main ballroom is reached. Virtual registration will remain open during the conference. Workshop registration will close on October 2, 2023, or when capacity is reached for each workshop.

The American Board of Lifestyle Medicine (ABLM) certification exam, traditionally offered at the end of the annual conference, will be offered on a day of the participant’s choice between November 25 and December 10, 2021, at Prometric testing centers across the U.S. Registration for the exam will close at 6 p.m. PST on September 30, 2023. Only attendance in-person at the 2023 conference will fulfill the “live” CME prerequisite for the 2023 ABLM exam.

ABOUT THE AMERICAN COLLEGE OF LIFESTYLE MEDICINE: ACLM is the medical professional society providing quality education and certification to those dedicated to clinical and worksite practice of evidence-based lifestyle medicine as the foundation of a transformed and sustainable health care system. ACLM educates, equips, empowers and supports its members as they provide evidence-based Lifestyle Medicine as the first treatment option in clinical practice and worksite settings through live and online CME- and CE-accredited events and educational offerings, certification, clinical practice tools, patient education resources, economic research, networking opportunities and advocacy efforts. ACLM members are united in their desire to identify and eradicate the root cause of disease and restore health. Learn more at lifestylemedicine.org.

ABOUT LORE HEALTH: Lore has cracked the code on the payment model for lifestyle medicine providers. Lore is an online community where people explore healthy lifestyle ideas and work to improve their health between clinical touchpoints. To help incentivize healthy behaviors, Lore members can earn hundreds of dollars in healthy groceries for using tools like in-home tests and biosensors that measure how well their health actions are working. Along with the first national lifestyle medicine ACO, Lore now also offers delegated risk programs to existing ACOs, Medicare Advantage plans, and other commercial plans—with guaranteed savings for all groups. Learn more at lorehealthcare.com.

iuvo BioScience Partner Research Organization

Our growth initiatives driven by the strategic plan are ambitious, and Bobby’s leadership and finance skills will certainly add to our confidence in delivering against these plans.

ROCHESTER, N.Y. (PRWEB)
May 25, 2023

iuvo BioScience, a specialty CRO providing laboratory services, preclinical and clinical development services, and scientific consulting services to pharmaceutical and medical device customers, today announced it has hired Robert (Bobby) McFall, CPA, MBA, as their Director of Finance. This hire demonstrates iuvo’s continued commitment to serving our clients, differentiated expertise, and investment in the business to support the company’s growth trajectory.

Bobby is a well-established Finance executive who brings years of experience in all aspects of finance and accounting, specifically in the healthcare industry. Bobby received his Bachelor of Business Administration and MBA from St Bonaventure University. As a CPA he began his career in public accounting at KPMG and then joined Carestream Health where his career progressed through a series of positions including Corporate Accounting and Financial Reporting Manager, Assistant Controller and, ultimately, Corporate Strategy & Finance Manager. In this role, Bobby also served as Chair of the Corporate Finance Committee. Bobby brings a wealth of financial expertise to iuvo as well as experience leading and supporting mergers and acquisitions.

McFall is excited to join the iuvo team, stating, “the foundation of the company is solid, and the strategic plan that has been developed for the company is impressive. I look forward to being part of the team and driving the delivery of the strategic plan as well leading the Finance team and setting the stage for long-term success.”

Daniel Spasic, Board Chair of iuvo BioScience, said, “we are excited to welcome Bobby to the iuvo family. Our growth initiatives driven by the strategic plan are ambitious, and Bobby’s leadership and finance skills will certainly add to our confidence in delivering against these plans. We look forward to working with Bobby and wish him all the best in this important role.”

Finally, Ben Burton, CEO of iuvo BioScience, commented, “the timing could not be better for adding Bobby to our team. I look forward to working with him as a member of our Executive Committee as we forge ahead with our growth strategy. We are excited to have Bobby on-board.”

About iuvo BioScience

Headquartered in Rochester, NY, iuvo BioScience is a highly specialized provider of preclinical, clinical, and consulting services to biotech and medical device customers. The company’s facility features laboratories for analytical chemistry, formulation, microbiology, and toxicology, as well as an on-site AAALAC-accredited vivarium to support preclinical testing. Through the company’s Oculos Clinical Research subsidiary, iuvo provides a suite of clinical trial services including clinical trial design, regulatory, biometrics, pharmacovigilance, project and site management. Under the Lumino Advisors brand, the company also has an end-to-end scientific consulting offering spanning from regulatory strategy, dossier development, preclinical and CMC consulting and strategic planning through trial execution and regulatory submission. Additional information about iuvo is available athttps:/http://www.iuvobioscience.com or follow us on LinkedIn.

Share article on social media or email:

We could not be more excited to welcome these companies into our 2023 cohort. All of them are solving some major challenges for people with disabilities and we believe that Remarkable can help ensure that people with disabilities are able to get access to these innovations quickly and affordably.

NEW YORK (PRWEB)
May 25, 2023

From brain-computer interface (BCI) technology in everyday life to extended reality (XR) navigation solutions, Remarkable has announced the innovative disability tech startups in their 2023 accelerator.

“Disability Tech continues to show strong growth as a sector, with a number of investment funds specifically focused on investing in this space, despite global headwinds in venture capital more generally. We are incredibly excited to see the 13 companies in this year’s global cohort. They represent the best emerging technologies in this exciting growth field,” said Pete Horsley, Founder of Remarkable.

The accelerator, which is made possible by Cerebral Palsy Alliance (CPA) and Cerebral Palsy Alliance Research Foundation (CPARF), has recently expanded to now run programs in Australia and the United States so that Remarkable can better support startups from across the globe.

This year, startups will be joining the accelerator from Australia, Canada, the United States and the United Kingdom. The demand for Remarkable’s global presence is also representative of the $13 trillion disability market and increased popularity of the global disabled and elderly assistive tech market, which is predicted to be worth $32 billion by 2026.

Remarkable Head of Programs Filipa Araújo shared, “The expanding Disability Tech market is a testament to the potent convergence of societal need and technological innovation. This aligns not just with financial prospects but also with a deeper mission — driving inclusivity and enhancing quality of life for people with disabilities. Our 2023 global accelerator cohort embodies this vision, with each startup leveraging technology to positively impact people with disability and amplify human potential.”

Remarkable US Director Molly Levitt explained, “We could not be more excited to welcome these companies into our 2023 cohort. All of them are solving some major challenges for people with disabilities and we believe that Remarkable can help ensure that people with disabilities are able to get access to these innovations quickly and affordably.”

Check out the startups completing Remarkable’s global programs this year listed in alphabetical order below:

•     Aurie is building a reusable no-touch catheter system to help intermittent catheter users avoid urinary tract infections. (US)
•     Enabled Play levels the playing field for people with disabilities by giving them new ways to control their technology that work for them. (US)
•     Focus Bear is a routine-building and anti-distraction app for neurodiverse individuals. (AUS)
•     Hominid X develops transformative assistive grasping devices to help individuals with hand disabilities to gain greater functional independence. (US)
•     Indii is enabling independence for disabled and older people by unlocking the potential of the smart home. (UK)
•     MEMORehab is an online platform on a mission to build better memory habits. (AUS)
•     Possibility Neurotechnologies is bridging the gap between BCI and everyday life, empowering individuals to control the world around them with just their thoughts. (Canada)
•     SignHow is changing the world one sign at a time. Empowering deaf people to build 300 sign languages together. (AUS)
•     SpineX Inc. is a clinical-stage bioelectric MedTech company committed to delivering spinal cord neuromodulation technologies to improve the lives of people with neurological conditions. (US)
•     Springrose designs adaptive intimate apparel that improves quality of life for women with limited mobility. (US)
•     The Care Co teaches kids aged 5-12 mental health habits in the classroom and beyond. (AUS)
•     Virtetic is empowering the prosthetics community through virtual reality. (AUS)
•     XR Navigation is making Audiom: The world’s most inclusive visual, auditory, and tactile digital-only map viewer. (US)

The 16-week accelerator equips these startups with seed funding* and the necessary knowledge, skills, and tools to become commercially viable businesses making a positive social impact. Through masterclasses, sprints, and deep dives, startups hone their work with personal coaches. It all culminates in pitches to more than 500 international investors, partners, and industry connections at Demo Day, which will take place on August 4, 2023, where the founders will showcase their growth, impact and goals. Follow our socials to stay up to date with this event!

*Startups in the Aus-based program receive $75,000 AUD worth of seed funding, which is made possible by CPA, icare**, Vivcourt, and Telstra Foundation. Startups in the US-based program receive $55,000 USD of funding, which is made possible by CPARF, the James and Pamela Griffith Family Foundation, and Aristocrat.

**icare only provides financial support to startups based in Australia.

ABOUT REMARKABLE

Remarkable is the startup venture arm of the Cerebral Palsy Alliance and Cerebral Palsy Alliance Research Foundation, with Australia-based support from icare NSW, Telstra Foundation, VivCourt, and TPG Telecom Foundation.

Remarkable offers a suite of programs amplifying disability tech startups from design-athons, pre-accelerators, accelerators and more. Since 2016, over 70 startups have come through the Remarkable programs and raised more than $35 million to amplify the potential of people with disabilities around the world.

The accelerator includes a 16-week program for startups with scalable products or service that leads to greater social or economic inclusion of people with a disability by providing seed funding, mentoring, coaching, investor networks, expertise and guidance. For more information, visit http://www.remarkable.org

ABOUT CEREBRAL PALSY ALLIANCE (CPA)

Cerebral Palsy Alliance provides family-centred therapies, life skills programs, equipment and support for more than 6,000 people with cerebral palsy and similar conditions throughout NSW and the ACT. For more than 75 years, our priority has been to enable those living with cerebral palsy to lead the most comfortable, independent and inclusive lives possible. CPA is also the world’s largest private funder of research into prevention and treatment of cerebral palsy through the CPA Research Foundation and CPA Research Institute. For more information, visit https://cerebralpalsy.org.au/.

ABOUT CEREBRAL PALSY ALLIANCE RESEARCH FOUNDATION (CPARF)

Cerebral Palsy Alliance Research Foundation funds US-based research to change what’s possible for people with cerebral palsy, implements proven science, and advances innovation to benefit all people with disabilities. Learn more at http://www.cparf.org.

Remarkable Contact

Vivien Mullan, Remarkable Marketing & Communications Manager

Email: vivien.mullan@remarkable.org

Mobile: +61 435 868 324

CPA Contact

Max Weber, Manager Media and Thought Leadership

Email: max.weber@cerebralpalsy.org.au

CPARF Contact

Jocelyn Cohen, Vice President of Communications and Engagement

Email: jocelyn.cohen@cparf.org

Share article on social media or email:

We are extremely honored and grateful to receive this distinguished recognition from Modern Healthcare…We want to express our deepest appreciation to our associates for their unwavering commitment to innovation through automation, which has enabled us to provide exceptional value to our clients.

FRANKLIN, Tenn. (PRWEB)
May 25, 2023

SureTest, Inc., a turnkey test automation solution provider to health systems for their enterprise EHR, third-party, and enterprise application testing processes, has been selected by Modern Healthcare as one of the 2023 Best Places to Work in Healthcare. This achievement is particularly noteworthy as it is the first year SureTest has been eligible for consideration for this prestigious award.

“We are extremely honored and grateful to receive this distinguished recognition from Modern Healthcare. The explosive growth our company has experienced over the past 18 months has been a testament to the dedication of our exceptional team at SureTest,” said Laura O’Toole, chief executive officer. “This award confirms that the cornerstone of the culture and commitment we have built for all our associates is strong, and it’s heartening to know that our efforts to create a supportive work environment have not gone unnoticed. We want to express our deepest appreciation to our associates for their unwavering commitment to innovation through automation, which has enabled us to provide exceptional value to our clients. In these challenging times, where doing more with less is the norm, having associates who feel supported, valued, and empowered to do meaningful work that creates a tangible difference for our clients is where the real magic lies!”

SureTest’s purpose is steadfast, with our people and clients at the center of everything we do. We remain focused on significantly impacting the healthcare industry with our managed service automation solution that jumpstarts innovation, reduces risk, and increases quality for our clients and the communities they serve.

The Modern Healthcare Best Places to Work award program identifies and recognizes outstanding employers in the healthcare industry nationwide. Modern Healthcare partners with Workforce Research Group on the assessment process, which includes an extensive employee survey.

“An uncertain economy, staffing shortages and increasing demands for flexibility and remote work opportunities are forcing every business in the industry to focus on attracting and retaining talent in unprecedented ways,” said Dan Peres, president of Modern Healthcare. “The 2023 Best Places to Work winners proved the value of understanding what employees want — and need — today. The healthcare industry is going through a period of extraordinary change. Having the right people in place is more critical than ever, and the winning workplaces understand that taking care of employees is central to business success.”

Official rankings will be announced at the 2023 Best Places to Work in Healthcare Awards Gala on Sept. 28 in Chicago. The complete list of this year’s winners, in alphabetical order, is available at ModernHealthcare.com/bestplaceslist.

About SureTest

SureTest is a leading enterprise solution company specializing in providing intelligent and streamlined automation to empower health systems to transform their EHR, third-party, and enterprise application testing process to repurpose or reduce thousands of staff hours annually. By leveraging the power of our solution, our clients can optimize their staff, realize game-changing efficiency, and improve patient care. Our solution precisely emulates the end-user and patient experiences and validates workflow integrity, resulting in a revolutionary approach to enterprise system application upgrades, optimizations, and new implementations. To learn more about how SureTest can help your organization achieve its goals, please visit us at SureTest.health. You can also follow us on LinkedIn.

Share article on social media or email:

“I am excited to make Atlanta my home and looking forward to providing exceptional care to my new community and patients,” says Dr. Supreet Kaur.

BROOKHAVEN, Ga. (PRWEB)
May 25, 2023

Elegant Smiles is a modern, state-of-the-art dental practice that provides cutting-edge, quality care for patients of all ages in a comfortable, relaxing environment. Elegant Smiles is committed to delivering comprehensive dentistry at its best, providing every patient with a pathway toward achieving functional and aesthetic smiles. Dr. Supreet Kaur is a welcome addition, and her dental knowledge and expertise are a great fit for this Atlanta area practice. Dr. Kaur is an experienced and compassionate dentist that is focused on patient care. She is skilled in restorative dentistry, root canal treatments, surgical extractions and fixed/removable appliances. Dr. Supreet Kaur is also clear aligner certified. Dr. Kaur earned her dental degree at the University of Iowa College of Dentistry and previously practiced in Pittsburgh, PA, before moving to the Atlanta region with her husband and two little ones. She led a previous life as a dentist in New Delhi, India, where she also earned a master’s degree in public health and supported an NGO focused on the dental health of needy children.

“I am excited to make Atlanta my home and looking forward to providing exceptional care to my new community and patients,” says Dr. Supreet Kaur.

More about Elegant Smiles:

With a convenient office location to serve residents of the Atlanta metro area at 1955 Cliff Valley Way in Brookhaven, Georgia, Elegant Smile’s highly skilled dentists specialize in all facets of dentistry, including general dentistry, cosmetic dentistry, restorative dentistry, pediatric dentistry and orthodontics (OrthoFX). They provide a wide menu of services, such as long-term solutions for sleep apnea, teeth grinding, jaw pain and crooked teeth. From tiny tots to senior citizens, they offer affordable, tailored treatments that meet expected and unexpected dental needs. Elegant Smiles offers emergency dental care, same day appointments, in-house financing plans and sedation dentistry.

For more information about services offered at Elegant Smiles, please visit http://www.dentalatl.com or call (404) 634-4224.

Share article on social media or email:

In the first quarter of 2023, Sunbit was added to more than 1,000 practices across the US, with 57,000 loans served, representing a $82.5 million lift in dental production.

“We were immediately impressed…Sunbit helps us serve virtually every patient, offer access to true no-interest plans, and overcome a historical pain point between our practice and our patients,” Dr. Raphael R. Putrus, DMD, MPH, MHA, Founder and CEO of All About Orthodontics.

LOS ANGELES (PRWEB)
May 25, 2023

Sunbit, the company building financial technology for everyday expenses, has rapidly become the financing technology partner of choice for DSOs, independent practices and dental industry groups. Working with Sunbit helps to deliver better financing experiences for patients, practices, and front office teams alike. Practices such as Let’s Go Dental have reported experiencing lifts in production of 50%, based on Sunbit’s fast, intuitive experience, suitability for virtually every patient, and unparalleled access to true no-interest plans. Sunbit also offers integrations with leading patient experience-focused dental software products.

“Sunbit has been our partner for over a year. We were immediately impressed by everything from their thoughtful approach to team training to the intuitive design of their product. And, they have delivered on every one of their promises. Sunbit helps us serve virtually every patient, offer access to true no-interest plans, and overcome a historical pain point between our practice and our patients,” said Dr. Raphael R. Putrus, DMD, MPH, MHA, Founder and CEO of All About Orthodontics.

In the first quarter of 2023, Sunbit was added to more than 1,000 practices across the US, with 57,000 loans served, representing a $82.5 million lift in dental production. This brings the total number of dental practices offering Sunbit’s point-of-sale lending technology to nearly 8,000, including more than 875 DSOs.

“I offer Sunbit to virtually every one of our patients. Helping my practice improve our bottom line while giving our patients an unforgettable experience makes me feel great about the work I do,” said Leslie Lytle, Practice Manager, Family Dental Care NC. “In a matter of seconds, I can share access to terms that are best-in-class, without a risk of late fees, origination fees, or penalties — quickly helping patients get to ‘yes’ on critical treatment plans. Our whole front office is proud to offer Sunbit.”

Sunbit’s technology offers access to financing for dental treatment costs between $50 and $20,000, with payment plan options ranging from 6 to 72 months. All qualified applicants get access to 6-, 9- and 12-month, true 0% interest payment plans at participating practices. Sunbit technology powers the simple 30-second application process, with more than an 85% approval rate, which is among the highest in the industry.

Sunbit’s “Sunbeast” enablement program now includes nearly 30,000 dental professionals certified to offer Sunbit to patients. Unlike many vendors, Sunbit’s investment in training is significant. There is a formal certification program as well as continuing education and engagement programs offered through an online knowledge center, ongoing training events, competitions, award ceremonies, and a gamified rewards system, all delivered through a robust mobile app.

“After testing Sunbit against other financial solutions last year, they were the clear winner. Their ability to significantly increase revenue, while also creating happy patients, was unparalleled,” said Heather Cordova, CEO, Let’s Go Dental.

Sunbit provides all the necessary training, certification, and promotional materials for dental practices and DSOs so they have the tools to offer Sunbit’s technology to every patient, at every transaction.

Sunbit builds financial technology for real life. Our technology eases the stress of paying for life’s expenses by giving people more options on how and when they pay. Sunbit offers access to a next-generation, no-fee credit card that can be managed through a powerful mobile app, as well as a point-of-sale payment option available at more than 19,000 service locations, including auto dealership service centers, optical practices, dentist offices, veterinary clinics, and specialty healthcare services. Sunbit was included on the 2022 Inc. 5000 list. The financial technology company has also been named as a Most Loved Workplace®, Best Point of Sale Company, A N.A. Deloitte Technology Fast 500 company and as a Top Fintech Startup by CB Insights. Loans are made by Transportation Alliance Bank, Inc., dba TAB Bank, which determines qualifications for and terms of credit. The Sunbit Card is issued by TAB Bank, pursuant to a license from Visa U.S.A. Inc. Use of the card is subject to the cardholder agreement.

Sunbit social handles:

LinkedIn

Twitter

Instagram

Facebook

Share article on social media or email:

Catalent’s Clinical Supply Facility in Shiga, Japan

The market in Japan for advanced therapies and new modalities continues to grow, along with the demand for companies such as Catalent that have the advanced infrastructure to handle the supply and distribution of these highly sensitive products.

SOMERSET, N.J. (PRWEB)
May 25, 2023

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that it has expanded the services and capabilities at its facility in Shiga, Japan, to include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials.

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational advanced therapy products by minimizing their time-out-of-environment. The expansion forms part of Catalent’s ongoing global strategy to increase its ability to handle, store and manage advanced therapies for clinical supply, and follows investments at its facilities in Philadelphia, Singapore, and Shanghai, China, in specialized, ultra-low temperature storage capabilities.

The 6,000-square-meter Shiga site opened in October 2021 to support customers both locally and globally, providing flexible clinical supply solutions, including primary packaging, Catalent’s FastChain® demand-led supply, white glove handling and logistics.

“The market in Japan for advanced therapies and new modalities continues to grow, along with the demand for companies such as Catalent that have the advanced infrastructure to handle the supply and distribution of these highly sensitive products, as well as the specialized expertise and comprehensive knowledge to manage these supply chains,” commented Tadahiro Matsumura, Catalent’s President of Japan. He added, “This investment allows us to provide the optimum logistical solution for every customer’s individual needs, and the foundation to increase capacity as requirements change and grow.”

With sites in the U.S., U.K., Germany, Singapore, Japan and China, and an extended network of over 50 depots, Catalent’s clinical supply services meet a broad range of international compliance and distribution requirements to support global clinical trials.

For further information on Catalent’s clinical supply services, visit https://www.clinical.catalent.com.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email: